Role of fecal calprotectin testing to predict relapse in teenagers with inflammatory bowel disease who report full disease control

American College of Rheumatology/European League Against Rheumatism Provisional Definition of Remission in Rheumatoid Arthritis for Clinical Trials

(2011) D. T. Felson et al.   ANNALS OF THE RHEUMATIC DISEASES

Use of C-Reactive Protein in Children with Newly Diagnosed Inflammatory Bowel Disease

(2011) Anne Tsampalieros et al.   JOURNAL OF PEDIATRICS

Fecal calprotectin is a predictive marker of relapse in Crohnʼs disease involving the colon: a prospective study

(2010) Lamia Kallel et al.   EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY

Pediatric modification of the Montreal classification for inflammatory bowel disease

(2010) Arie Levine et al.   INFLAMMATORY BOWEL DISEASES

Faecal calprotectin in children with clinically quiescent inflammatory bowel disease

(2010) Taina Sipponen et al.   SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY

Fecal Calprotectin Correlates More Closely With the Simple Endoscopic Score for Crohn's Disease (SES-CD) than CRP, Blood Leukocytes and the CDAI

(2009) Alain M Schoepfer et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Ulcerative colitis

(2009) Alain M. Schoepfer et al.   INFLAMMATORY BOWEL DISEASES

Fecal calprotectin and lactoferrin for the prediction of inflammatory bowel disease relapse

(2009) Javier P. Gisbert et al.   INFLAMMATORY BOWEL DISEASES

Clinical implications of mucosal healing for the management of IBD

(2009) Guillaume Pineton de Chambrun et al.   Nature Reviews Gastroenterology & Hepatology

Can Calprotectin Predict Relapse Risk in Inflammatory Bowel Disease?

(2008) Renata D'Incà et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Faecal calprotectin as reliable non-invasive marker to assess the severity of mucosal inflammation in children with inflammatory bowel disease

(2008) R. Berni Canani et al.   DIGESTIVE AND LIVER DISEASE

Clinical role of calprotectin assay in determining histological relapses in children affected by inflammatory bowel diseases

(2008) A. Diamanti et al.   INFLAMMATORY BOWEL DISEASES

Fecal calprotectin, lactoferrin, and endoscopic disease activity in monitoring anti-TNF-alpha therapy for Crohnʼs disease

(2008) Taina Sipponen et al.   INFLAMMATORY BOWEL DISEASES

Noninvasive Markers in the Assessment of Intestinal Inflammation in Inflammatory Bowel Diseases: Performance of Fecal Lactoferrin, Calprotectin, and PMN-Elastase, CRP, and Clinical Indices

(2007) Jost Langhorst et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY